8 / 18
Page 35
Notes:
conferenceseries
.com
Volume 8
Journal of Clinical & Experimental Pharmacology
Pharmacology and Medicinal Chemistry 2018
October 18-19, 2018
October 18-19, 2018 Dubai, UAE
International Conference on
18
th
International Conference on
&
Joint Meeting on
Pharmacology and Toxicology
Medicinal and Pharmaceutical Chemistry
Common reasons for rejection of scientific manuscripts in pharmacology
Rajan Radhakrishnan
Mohammed Bin Rashid University of Medicine and Health Sciences, UAE
A
significant number of manuscripts submitted to international scientific journals are from China, India, Pakistan and other
developing countries. However, the acceptance rates of manuscripts from these countries are much lower than the average
acceptance rates of manuscripts in these journals. Major reasons for rejection are: (1) Flawed study design, (2) inappropriate
data analysis methods, (3) lack of study justification, (4) lack of novelty/data duplication, (5) lack of chemical fingerprinting/
standardization of extracts, (6) study conclusions without supporting data and (7) poor writing style, language, formatting.
This presentation will focus on the details of common reasons for rejection and suggestions for improvement.
Biography
Rajan Radhakrishnan is a Pharmacologist and a US-registered pharmacist, currently serving as a professor of pharmacology at the Mohammed Bin Rashid
University College of Medicine in Dubai. He has more than 20 years of combined experience in teaching, research, and academic administration. He received his
BPharm degree from the University of Kerala, India; MSc in pharmacology from the University of Strathclyde, UK; and PhD in pharmacology from the National
University of Singapore (NUS). He did his postdoctoral fellowship in pain neurobiology at the University of Iowa, USA. He has taught pharmacology to pharmacy,
medical and dental students in different universities in Malaysia, USA and UAE. He has also served as the Academic Affairs Dean at the Schools of Pharmacy
in Roseman University and University of Charleston in the USA. Dr. Radhakrishnan is an active member of the American Association of Colleges of Pharmacy
(AACP), American Pain Society (APS), and Society for Neuroscience (SFN). He has published 40 peer-reviewed research articles, 5 book chapters and several
abstracts. He is one of the editors of
Phytotherapy Research
(Wiley), Section Editor of
Inflammopharmacology
(Springer) and Editorial Board Member of
Journal
of Pain
(Elsevier). He is also in the reviewer panel of more than 15 International scientific journals. His current research interests are pain neurobiology, herbal
medicine, and scholarship of teaching and learning (SoTL ).
rajan.radhakrishnan@mbru.ac.aeRajan Radhakrishnan, Clin Exp Pharmacol 2018, Volume 8
DOI: 10.4172/2161-1459-C3-034